Search for: "Astrazeneca"
Results 381 - 400
of 1,244
Sort by Relevance
|
Sort by Date
9 Sep 2015, 6:11 am
Of that amount, AstraZeneca will pay roughly $26.7 million, plus interest, to the United States, and the remainder to states participating in the settlement. [read post]
6 Sep 2015, 12:30 am
Last week I predicted that the High Court would affirm the finding of five judges of the Federal Court of Australia that AstraZenenca’s patents covering low-dosage forms of the cholesterol-lowering drug marketed as CRESTOR (having the active ingredient rosuvastatin) are invalid on grounds of obviousness.In the much-anticipated decision in AstraZeneca AB v Apotex Pty Ltd (et al) [2015] HCA 30, five judges of the High Court, in four distinct concurring opinions, have unanimously… [read post]
29 Aug 2015, 9:08 pm
At 10.15am this coming Wednesday (2 September 2015) the Australian High Court will hand down its decision in the appeal by AstraZeneca AB against last year’s ruling, by a a special five-judge panel of the Federal Court of Australia, that its two patents relating to the cholesterol-lowering drug marketed as CRESTOR (having the active ingredient rosuvastatin) are invalid.The decision will be significant in clarifying the law relating to obviousness in Australia. [read post]
25 Aug 2015, 8:54 am
AstraZeneca, through its wholly owned subsidiary MedImmune, based in Gaithersburg, Maryland, is currently running clinical trials at 20 sites across the country on a newly approved “Orphan drug” designed to treat mesothelioma. [read post]
25 Aug 2015, 7:10 am
Other inhibitors in this class include Farxiga and Xigduo by AstraZeneca, Jardiance by Lilly, and Glyxambi by Boehringer Ingelheim. [read post]
30 Jul 2015, 4:46 am
This disclosure, although it does not provide pay ratios, was provided by companies that all employed more than 1,000 employees (or, with respect to Aon, Astrazeneca, Avery Dennison and Reed Elsevier, employed more than 25,000 employees), and indicates the type of compensation used and the employees considered for the disclosure. [read post]
23 Jul 2015, 1:10 pm
We are watching to see whether the FDA will follow the advice given at this April 2015 Advisory Committee meeting and mandate that AstraZeneca revise the drug labels for Onglyza and Kombiglyze XR to warn about the increase risks of side effects. [read post]
14 Jul 2015, 8:23 am
Allegedly violating the FCA is not new for AstraZeneca. [read post]
14 Jul 2015, 6:40 am
AstraZeneca and Cephalon, two of the country’s leading biopharmaceutical suppliers, agreed to pay the government a settlement of $54.4 million… The post Two Biopharmaceutical Companies Resolve Allegations of Violating the False Claims Act By Underpaying Rebates, and Agree to Pay U.S. [read post]
10 Jul 2015, 11:46 am
AstraZeneca and Cephalon chose to settle the case, resolving the allegations against them. [read post]
9 Jul 2015, 2:51 pm
AstraZeneca manufactures Farxiga and Xigduo, Jardiance and Glyxambi is made by Lilly and Boehringer Ingelheim. [read post]
8 Jul 2015, 8:31 am
Perhaps the most famous examples are AstraZeneca’s prescription drugs Prilosec® and Nexium®, both known in the market place as the “Purple Pill. [read post]
5 Jul 2015, 12:59 pm
AstraZeneca, Pfizer and Allergan were other big spenders in the category of general payments. [read post]
22 Jun 2015, 9:24 am
******************PREVIOUSLY, ON NEVER TOO LATE Never too late 50 [week ending on Sunday 7 June] - Swiss claims | Italian-sounding trade marks for cosmetics | “IP litigation and Enforcement” event | Saving WiFi | Spy scandal at the EPO | Rihanna v DC Comics | KitKat trade mark | Taste trade marks in the Netherlands | Connectivity and human rights | Trade secrets, client confidentiality and privilege | 3-d printing and counterfeiting | Ericsson v Apple in the… [read post]
15 Jun 2015, 10:27 pm
In Astrazeneca v. [read post]
15 Jun 2015, 7:13 am
******************PREVIOUSLY, ON NEVER TOO LATE Never too late 49 [week ending on Sunday 31 May] - Another copyright-exhaustion-and-software reference to the CJEU | ORO trade marks and GC | Patent Reform in EU | Copyright in the Bahamas | More and more references to the CJEU: communication to the public and linking | Trade secrets and the FoMo phenomenon | Independence of EPO’s BoA.Never too late 48 [week ending on Sunday 31 May] - The… [read post]
15 Jun 2015, 3:57 am
Among the PPIs identified in the study as linked to an increased risk of heart attack, the following are common in prescription or over- the-counter form: • Prilosec – manufactured by AstraZeneca • Prilosec OTC – manufactured by Procter & Gamble • Nexium – manufactured by AstraZeneca and now available over the counter • Zegerid OTC – manufactured by Merck & Col and Santarus, Inc. [read post]
10 Jun 2015, 11:51 am
This class of drugs consists of: Invokana — Janssen Pharmaceuticals — FDA Approval: 2013Invokamet — Janssen Pharmaceuticals — FDA Approval: 2014Farxiga — AstraZeneca Pharmaceuticals — FDA Approval: 2014Xigduo XR — AstraZeneca Pharmaceuticals — FDA Approval: 2014Jardiance — Boehringer Ingelheim Pharmaceuticals — FDA Approval: 2014Glyxambi — Boehringer Ingelheim Pharmaceuticals — FDA Approval: 2015 In this… [read post]
9 Jun 2015, 1:06 pm
But, according to AboutLawsuits.com, the BMJ editors also noted that Young has served as an advisor for major drug companies that manufacture drugs to treat some mental disorders, including AstraZeneca, which makes Seroquel, Lundbeck, which makes Abilify and Lexapro, and Eli Lilly, which makes Prozac. [read post]
8 Jun 2015, 4:20 am
******************PREVIOUSLY, ON NEVER TOO LATE Never too late 48 [week ending on Sunday 31 May] - The meaning of EPO appeal system | 3D Printing and the law | Epo and external investigation firms | Umbrella designs | US Supreme Court in Commil USA, LLC v Cisco Systems | European Inventor Award | FIFA and brand integrity | Warner-Lambert v Actavis | Wine in Black GmbH v OHIM | IP and busking | Swiss-style claims.Never too late… [read post]
